# IC14 for Treatment of Acute Decompensated Heart Failure

> **NCT06556810** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Implicit Bioscience** · enrollment: 10 (estimated)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** Atibuclimab (IC14)

## Key facts

- **NCT ID:** NCT06556810
- **Lead sponsor:** Implicit Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-17
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-08-28
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556810, "IC14 for Treatment of Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06556810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*